Dr
Laurence
Gainey

Patent Director

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 778 545 8684
Email. [email protected]

Experience

Laurence is a highly-experienced European and UK qualified patent attorney with over 25 years’ experience handling pharmaceutical and biotechnology subject matter. He has successfully managed patent portfolios on a variety of biotechnology subject matter, including diagnostic tools and targets, personalised healthcare (PHC), antisense oligonucleotide molecules, peptide and antibody (e.g. polyclonal, monoclonal, bispecific and conjugated) therapeutics, as well as handling the IP for small molecule discovery and high profile on sale pharmaceutical products, some with greater than $1bn annual sales.

After gaining a PhD in molecular biology from Reading University, Laurence joined a small biotechnology company to work in the laboratory on virus-based antigen delivery systems. After a couple of years, he moved internally to train as a patent attorney. In the same year as qualifying as European patent attorney Laurence joined the in-house patent department of AstraZeneca Pharmaceutical Ltd. where he worked for over 18 years before joining HGF’s Manchester office as a Patent Director in September 2017.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Cell and Molecular Biology

PHD

Molecular Biology - Reading University

POSTGRADUATE DIPLOMA OR CERTIFICATE

Certificate in Intellectual Property Law - Queen Mary University of London

Publications

Personalised drug patenting in Europe

View publication online

T0694/16 - New EPO Technical Board of Appeal decision regarding personalised healthcare inventions

View publication online

MBL Webinar entitled "Patent Due Diligence - The Fundamental Portfolio Checks Required"

View publication online

Chapter "Patent Considerations When Embarking on New Antisense Drug Programs" for the Open Access book "Antisense RNA Design, Delivery, and Analysis". "

View publication online

Conferences: 2022

June 27th 2022

Webinar: A comparison of IP Practice in EU, US and JP for new medical use and method of treatment patenting

Speaker

Event details

Conferences: 2021

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2019

October 17th 2019

Seminar: Strategies and updates on patenting inventions relating to personalised medicine in Europe and the US - Basel

Speaker

Event details

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Dot Inc, the accessible future and more: health tech highlights coming to CES 2023

The countdown is on for CES 2023. Taking place in Las Vegas in the first week of January each year, CES sets the global stage for innovation in the tech …

Read article

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.